With so many shares to choose from on the S&P/ASX 200 Index (ASX: XJO), it can be hard to decide which ones to buy.
The good news is that brokers across the country are doing a lot of the hard work for you.
Three top shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:
BlueScope Steel Limited (ASX: BSL)
According to a note out of Goldman Sachs, its analysts have upgraded this steel producer's shares to a buy rating with an increased price target of $14.95. The broker made the move after steel spreads improved in Asia and North America. Goldman expects these improvements to continue over the coming months as supply and demand begins to rebalance again. Especially given increasing demand in Australia following additional government stimulus in the construction sector. While it isn't a company that I'm a big fan of, I think the broker makes some great points.
BWP Trust (ASX: BWP)
Analysts at Ord Minnett have upgraded this property company's shares to a buy rating and lifted the price target on them to $4.40. The broker notes that funds are flowing back into the property sector and is recommending investors look at companies with long leases. It believes these are undervalued in comparison to others in the sector. BWP ticks a lot of boxes for the broker, hence its upgrade to buy this morning. I agree with Ord Minnett and would be a buyer of BWP's shares.
Healius Ltd (ASX: HLS)
A note out of the Macquarie equities desk reveals that its analysts have upgraded this healthcare company's shares to an outperform rating with an improved price target of $3.00. Macquarie believes that Healius won't be impacted by the pandemic as much as previously expected. It also feels the company is well-placed to benefit from an increase in activity in the near term. In addition to this, it appears to see the potential divestment of its medical centres as a positive. While not my favourite option in the healthcare sector, I think Healius is still worth a closer look.
